10.1021/tx000180q 132 KatoN.YanakaK.NagaseS.HirayamaA.NoseT.MathiesenT
While routine liver function testing is not standard for all patients on semaglutide, those with known hepatic disease may benefit from periodic assessment of ALT, AST, alkaline phosphatase, and bilirubin levels
So if I am able to attain this CoA for my weight management program, you would think a state Board of Pharmacy would be able to do the same and ban only semaglutide salt and not the approved base
CrossRef AMPK activator-mediated inhibition of endoplasmic reticulum stress ameliorates carrageenan-induced insulin resistance through the suppression of selenoprotein P in HepG2 hepatocytes Tae Woo Jung, So Young Lee, Ho Cheol Hong, Hae Yoon Choi, Hye Jin Yoo, Sei Hyun Baik, Kyung Mook Choi Molecular and Cellular Endocrinology.2014